References
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, ATS/ERS Task Force, et al. Standardisation of lung function testing. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
- Nannini LJ, Neumayer NS, Brandan N, Fernández OM, Flores DM. Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen. Eur Clin Respir J. 2022;9(1):2110706. doi:10.1080/20018525.2022.2110706.
- Global Initiative for Asthma. Global strategy for asthma management and prevention; 2012. [accessed 2020 Aug 9].
- Anderson GP. Formoterol: pharmacology, molecular-basis of agonism, and mechanism of long-duration of a highly potent and selective beta(2)-adrenoceptor agonist bronchodilator. Life Sci. 1993;52(26):2145–2160. doi:10.1016/0024-3205(93)90729-m.
- Balanag VM, Yunus F, Yang P-C, Jorup C. Budesonide/formoterol in a single inhaler is as effective and well-tolerated as salbutamol in relieving acute asthma in adults and adolescents [abstract]. Eur Respir J. 2003;22:445s.
- Bateman ED, Fairall L, Lombardi DM, English R. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res. 2006;7(1):13. 24 PMID: 16433920; PMCID: PMC1386666. doi:10.1186/1465-9921-7-13.
- Nannini LJ, Brandan N, Fernandez OM. Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina. J Asthma. 2023;60(6):1057–1060. doi:10.1080/02770903.2022.2137036.
- Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Erzurum SC, Gaston BM, Israel E, for the National Heart, Lung, Blood Institute Severe Asthma Research Program, et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985). 2008;104(2):394–403. doi:10.1152/japplphysiol.00329.2007.
- Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R, Castro M, Curran-Everett D, Fitzpatrick AM, National Heart, Lung, and Blood Institute’s Severe Asthma Research Program, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–323. doi:10.1164/rccm.200906-0896OC.
- Global Initiative for Asthma. Global strategy for asthma management and prevention 2022. Available from: www.ginasthma.org.
- Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O. Non-genomic Effects of Glucocorticoids: an Updated View. Trends Pharmacol Sci. 2019; Jan40(1):38–49. Epub 2018 Nov 26. PMID: 30497693; PMCID: PMC7106476. doi:10.1016/j.tips.2018.11.002.
- Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest. 2006; Nov130(5):1301–1311. PMID: 17099004. doi:10.1378/chest.130.5.1301.
- Nannini LJ. Treat to target approach for asthma. J Asthma. 2020;57(6):687–690. doi:10.1080/02770903.2019.1591443.